Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia

Functional Role of Soluble Receptor for Advanced Glycation End Products in Stroke

(2013) Sung-Chun Tang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cellular signalling of the receptor for advanced glycation end products (RAGE)

(2013) Jianling Xie et al.   CELLULAR SIGNALLING

Evidence for a detrimental role of TLR8 in ischemic stroke

(2013) Sung-Chun Tang et al.   EXPERIMENTAL NEUROLOGY

RAGE and TLRs: Relatives, friends or neighbours?

(2013) Zaridatul Aini Ibrahim et al.   MOLECULAR IMMUNOLOGY

Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways

(2013) Kazuki Murakami et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways

(2012) Alexander Widiapradja et al.   JOURNAL OF NEUROCHEMISTRY

Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia

(2011) Bolanle M. Famakin et al.   BRAIN RESEARCH

Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes

(2011) Mark Ballow et al.   CLINICAL IMMUNOLOGY

Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

(2011) David Brea et al.   CLINICAL IMMUNOLOGY

HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation

(2011) José Augusto Nogueira-Machado et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Evidence that  -Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor- B-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke

(2011) T. V. Arumugam et al.   MOLECULAR PHARMACOLOGY

IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients

(2010) Aharon Kessel et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Intravenous immunoglobulins - understanding properties and mechanisms

(2009) A. Durandy et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Toll-like receptor signaling in cell proliferation and survival

(2009) Xinyan Li et al.   CYTOKINE

Intravenous Immunoglobulin Reduces Infarct Volume but Not Edema Formation in Acute Stroke

(2009) Maureen Walberer et al.   NEUROIMMUNOMODULATION

DC-SIGN and  2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells

(2009) J. Bayry et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY

(2009) Thiruma V. Arumugam et al.   SHOCK

Toll-like receptors in neurodegeneration

(2008) Eitan Okun et al.   BRAIN RESEARCH REVIEWS

Toll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation

(2008) J. D. Lathia et al.   JOURNAL OF NEUROSCIENCE

Modulation of the cellular immune system by intravenous immunoglobulin

(2008) Thanyalak Tha-In et al.   TRENDS IN IMMUNOLOGY